US Faces High Risks From Heavy Reliance On Chinese Pharmaceuticals: Report
The analysis criticised the minimal inspection capacity of the US Food and Drug Administration (FDA) at Chinese manufacturing facilities.
The analysis criticised the minimal inspection capacity of the US Food and Drug Administration (FDA) at Chinese manufacturing facilities.
